Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

Rhea-AI Summary

Codexis (NASDAQ: CDXS), an enzyme engineering company, announced its participation in the TD Cowen 2nd Annual Sustainability Week from May 21-23, 2024. The company will join a panel on May 22, 2024, to discuss “Sustainable API Manufacturing” focusing on the benefits of enzymatic synthesis in creating small molecule and siRNA therapeutics. The event will be live-streamed and available for replay on the Codexis website.

Positive

• Participation in a high-profile event like TD Cowen's Sustainability Week can increase Codexis's visibility and credibility in the enzyme engineering sector.
• Highlighting the potential benefits of enzymatic synthesis may attract new investors interested in sustainable and innovative manufacturing processes.
• The webcast availability increases accessibility for a broader audience, potentially leading to wider interest and stakeholder engagement.

Negative

• The announcement does not include any new financial data or concrete business developments, leaving investors without critical performance metrics.
• Participation in the event itself does not guarantee any immediate financial benefit or stock price increase for Codexis.
• The focus on sustainability, while positive, might not directly address current financial challenges or immediate revenue growth concerns.

REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a panel discussion titled, “Sustainable API Manufacturing” at the TD Cowen 2^nd Annual Sustainability Week, being held virtually May 21-23, 2024. During the presentation, Management will highlight the potential benefits of an enzymatic route of synthesis in the manufacture of small molecule and siRNA therapeutics.

The panel will take place on Wednesday, May 22, 2024, at 4:25 pm ET. A live webcast of the event will be available here and in the Investor Relations section of the Company’s website, https://www.codexis.com/investors. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com

Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com

FAQ

What is Codexis's stock symbol?

Codexis's stock symbol is CDXS.

What event is Codexis participating in?

Codexis is participating in the TD Cowen 2nd Annual Sustainability Week from May 21-23, 2024.

When is Codexis's panel discussion scheduled?

Codexis's panel discussion on “Sustainable API Manufacturing” is scheduled for May 22, 2024, at 4:25 pm ET.

What will Codexis discuss during their panel?

Codexis will discuss the potential benefits of enzymatic synthesis in the manufacture of small molecule and siRNA therapeutics.

Where can I watch Codexis's panel discussion?

You can watch the live webcast of Codexis's panel discussion on the Codexis website under the Investor Relations section.

How long will the replay of the panel discussion be available?

The replay will be archived and available for 90 days following the event.